|DON'T BUY||$32.380||BULLISH||US EQUITIES||Unknown|
There will be a time when this will be a hero stock for someone who bought it at the low. However, that is a tough call to make. Your odds of getting it right are low. The whole space is highly political right now.
Chief Investment Officer, Equium Capital Management
Teva has taken on a lot of debt to add generics. On the branded side it's more about legal battles to extend Copaxone's patents than the product itself. There is value in the company that will eventually be realized, but yeah, maybe now is not quite the right time to be a hero.
You must be logged in to comment.